Drug
Flupenthixol
Flupenthixol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
4
80%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
NCT00000266
completedphase_2
Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000241
completedphase_2
Cocaine Abuse and ADHD - 10
NCT00000275
completedphase_2
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
NCT00000274
unknownphase_1
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
NCT00000349
Clinical Trials (5)
Showing 5 of 5 trials
NCT00000266Phase 2
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
NCT00000241Phase 2
Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000275Phase 2
Cocaine Abuse and ADHD - 10
NCT00000274Phase 2
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
NCT00000349Phase 1
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5